LIAISON<sup>®</sup> Calprotectin for the prediction of relapse in quiescent ulcerative colitis: The EuReCa study.

Gionata FiorinoSilvio DaneseLaurent Peyrin-BirouletMiquel SansFabrizio BonelliMariella CalleriClaudia ZieroldRoberta PollastroFabio MorettiAlberto Malesci

Published in: United European gastroenterology journal (2022)

The trial is registered at clinicaltrials.gov with reference number NCT05168917.

Keyphrases

ulcerative colitis
clinical trial
study protocol
phase iii
randomized controlled trial
phase ii
rheumatoid arthritis
disease activity